The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease. (Q54319662)

27 May 2018

title

The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease. (English)

1 reference

27 May 2018

chronic obstructive pulmonary disease

main subject

1 reference

Chiung-Zuei Chen

1

1 reference

27 May 2018

Chih-Ying Ou

2

1 reference

27 May 2018

Ru-Hsueh Wang

3

1 reference

27 May 2018

Cheng-Hung Lee

4

1 reference

27 May 2018

Chien-Chung Lin

5

1 reference

27 May 2018

Han-Yu Chang

6

1 reference

27 May 2018

Tzuen-Ren Hsiue

7

1 reference

27 May 2018

language of work or name

English

0 references

publication date

12 March 2012

1 reference

27 May 2018

COPD: Journal of Chronic Obstructive Pulmonary Disease

published in

1 reference

27 May 2018

volume

9

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

197-202

1 reference

27 May 2018

COPD in Asia: where East meets West

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

COPD prevalence in 12 Asia–Pacific countries and regions: Projections based on the COPD prevalence estimation model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Endotoxin exposure as a major determinant of lung function decline in pig farmers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Elastase- and LPS-exposed mice display altered responses to rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Listening to silence and understanding nonsense: exonic mutations that affect splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.654143

10.3109/15412555.2011.654143

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

22409502

1 reference

27 May 2018